- Home
- CIB vs EXEL Comparison
CIB vs EXEL Comparison
Compare CIB & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIB | EXEL |
|---|---|---|
| Founded | 1945 | 1994 |
| Country | Colombia | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 14.0B |
| IPO Year | 2025 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CIB | EXEL |
|---|---|---|
| Price | $81.82 | $55.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 21 |
| Target Price | ★ $70.25 | $46.50 |
| AVG Volume (30 Days) | 336.4K | ★ 2.5M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | ★ 57.95 |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $452,477,000.00 |
| Revenue This Year | $56.74 | $13.61 |
| Revenue Next Year | $8.05 | $13.13 |
| P/E Ratio | ★ $10.87 | $70.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.20 | $33.76 |
| 52 Week High | $87.68 | $57.57 |
Technical Indicators
Market Signals| Indicator | CIB | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 60.20 | 58.46 |
| Support Level | $61.61 | $40.77 |
| Resistance Level | $83.13 | $57.57 |
| Average True Range (ATR) | 2.01 | 1.52 |
| MACD | -0.20 | 0.00 |
| Stochastic Oscillator | 66.09 | 66.44 |
Price Performance
Historical ComparisonAbout CIB BanColombia S.A.
Grupo Cibest SA is a full service financial group offering a broad range of financial products and services to a diversified individual and corporate clients through subsidiaries. Its network also includes offshore banking subsidiaries in Panama and Puerto Rico, as well as other adjacent businesses. Its products and services include Savings and Investment, Financing, Factoring, Financial and Operating Leases, Capital Markets, Trading, Cash Management, Foreign Currency and Trade Finance, Bancassurance and Insurance, Investment Banking, Trust and Fiduciary Services, Mortgage Lending Business, among others. Its segments include Banking Colombia, Banking El Salvador, Banking Guatemala, International Banking, Leases, All Other and Banking Panama.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.